News: NYR Zinc stocks slide as shortages in Europe persist, page-19

Don't waste your time mate. There's always one, apparently holding but slagging it off.. But to that point, its not even close to a shell yet with two very prospective drugs about to commence trials and cash in the bank.

Story hasn't changed for NYR, delays have been frustrating, but a bucket load of cash means no dilution.. Add to that the broader market sell off and more recently tax loss selling and here we are, trading near enough to all time lows. Very temped to go again (top up) with a big 6-12 months of news flow ahead.